Anzeige
Mehr »
Login
Mittwoch, 04.12.2024 Börsentäglich über 12.000 News von 680 internationalen Medien
Analysten eilen, um Kursziele zu verdreifachen nach ATHAs neuester Entdeckung
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

GlobeNewswire (Europe)-Archiv vom 03.12.2024

ZeitNachrichten
Sprache: Alle DE EN
LeserMedien
DiGroupe Casino: Real estate disposals20Casino Group sells €77m of real estate assets to Groupement Les Mousquetaires Paris, 3 December 2024 Casino Group has signed a binding agreement to sell a portfolio of 69 real estate assets to Groupement...
► Artikel lesen
DiUnited Community Banks, Inc. and ANB Holdings, Inc., the Parent of American National Bank, Announce Merger Agreement3GREENVILLE, S.C., Dec. 03, 2024 (GLOBE NEWSWIRE) -- United Community Banks, Inc. (NYSE: UCB) ("United") and ANB Holdings, Inc. ("ANB") announced today the execution of a definitive merger agreement...
► Artikel lesen
DiProcaps Group, S.A.: Procaps Group Announces Financing, Shareholders Agreement and Board Updates65MIAMI and BARRANQUILLA, Colombia, Dec. 03, 2024 (GLOBE NEWSWIRE) -- Procaps Group, S.A. (NASDAQ: PROC) ("Procaps" or the "Company"), a leading integrated LatAm healthcare and pharmaceutical services...
► Artikel lesen
DiTavia Acquisition Corp. Announces Pricing of $100 Million Initial Public Offering35London, United Kingdom, Dec. 03, 2024 (GLOBE NEWSWIRE) -- Tavia Acquisition Corp. (the "Company") announced today the pricing of its initial public offering of 10,000,000 units, at a price of $10.00...
► Artikel lesen
DiK92 Mining Inc.: K92 Mining Announces Multiple New Near-Mine Infrastructure Dilatant Zones Identified and High-Grade Zones Extended79VANCOUVER, British Columbia, Dec. 03, 2024 (GLOBE NEWSWIRE) -- K92 Mining Inc. ("K92" or the "Company") (TSX: KNT; OTCQX: KNTNF) is pleased to announce its latest high-grade results from the ongoing...
► Artikel lesen
DiThe Descartes Systems Group Inc: Descartes Announces Fiscal 2025 Third Quarter Financial Results46Record Revenues as Global Logistics Network ExpandsWATERLOO, Ontario and ATLANTA, Dec. 03, 2024 (GLOBE NEWSWIRE) -- The Descartes Systems Group Inc. (TSX:DSG) (Nasdaq:DSGX) announced its financial...
► Artikel lesen
DiMalcolm Wilson to Retire as CEO of GXO Logistics in 202540GREENWICH, Conn., Dec. 03, 2024 (GLOBE NEWSWIRE) -- GXO Logistics, Inc. (NYSE: GXO) today announced that Malcolm Wilson, chief executive officer, has informed the board of directors that he plans...
► Artikel lesen
DiAclaris Therapeutics, Inc.: Aclaris Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)30WAYNE, Pa., Dec. 03, 2024 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS)(the "Company" or "Aclaris"), a clinical-stage biopharmaceutical company focused on developing novel drug candidates...
► Artikel lesen
DiXilio Therapeutics, Inc.: Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)19WALTHAM, Mass., Dec. 03, 2024 (GLOBE NEWSWIRE) -- Xilio Therapeutics, Inc. (Nasdaq: XLO), a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology therapies...
► Artikel lesen
DiOlema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)21SAN FRANCISCO, Dec. 03, 2024 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc. ("Olema" or "Olema Oncology", Nasdaq: OLMA), a clinical-stage biopharmaceutical company focused on the discovery, development...
► Artikel lesen
DiOutlook Therapeutics, Inc.: Outlook Therapeutics Announces Executive Leadership Transition30ISELIN, N.J., Dec. 03, 2024 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company that achieved regulatory approval in the European Union and the United Kingdom...
► Artikel lesen
DiMural Oncology, Inc.: Mural Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)19WALTHAM, Mass and DUBLIN, Dec. 03, 2024 (GLOBE NEWSWIRE) -- Mural Oncology plc (Nasdaq: MURA), a clinical-stage immuno-oncology company developing novel, investigational engineered cytokine therapies...
► Artikel lesen
DiTeraWulf Inc.: TeraWulf Announces November 2024 Production and Operations Update41Completed critical electrical upgrades to support Lake Mariner HPC hosting and mining buildings Remain on schedule to deliver 72.5 MW of HPC hosting capacity by the end of Q2 2025 Successfully...
► Artikel lesen
DiNeuroPace, Inc.: NeuroPace Completes Enrollment in Feasibility Study of RNS System for Lennox-Gastaut Syndrome20MOUNTAIN VIEW, Calif., Dec. 03, 2024 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a commercial-stage medical device company focused on transforming the lives of people living with epilepsy...
► Artikel lesen
DiX4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)16BOSTON, Dec. 03, 2024 (GLOBE NEWSWIRE) -- X4 Pharmaceuticals (Nasdaq: XFOR), a company driven to improve the lives of people with rare diseases of the immune system, today announced that, effective...
► Artikel lesen
DiInotiv, Inc.: Inotiv Reports Fourth Quarter and Full Year Financial Results for Fiscal 2024 and Provides Business Update28- Enhanced liquidity through issuance of Second Lien Notes - Obtained amendment to credit agreement and extended note payable - Fourth quarter fiscal 2024 revenue down 7.3% to $130.4 million -...
► Artikel lesen
DiMachTen, Inc. Reports Third Quarter 2024 Financial Results35TRAVERSE CITY, Mich., Dec. 03, 2024 (GLOBE NEWSWIRE) -- MachTen, Inc. ("MACT") (OTC: MACT) today reported financial results for the quarter ended September 30, 2024. Financial Highlights Financial...
► Artikel lesen
DiAnfield Energy Inc. Announces Shareholder Approval of Plan of Arrangement31VANCOUVER, British Columbia, Dec. 03, 2024 (GLOBE NEWSWIRE) -- Anfield Energy Inc. (TSX.V: AEC; OTCQB: ANLDF; FRANKFURT: 0AD) ("Anfield" or "the Company") is pleased to announce that the proposed...
► Artikel lesen
DiFate Therapeutics, Inc.: Fate Therapeutics Reports New Employee Inducement Award Under Nasdaq Listing Rule 5635(c)(4)14SAN DIEGO, Dec. 03, 2024 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bringing a first-in-class pipeline of induced pluripotent...
► Artikel lesen
DiIntellia Therapeutics, Inc.: Intellia Therapeutics Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)37CAMBRIDGE, Mass., Dec. 03, 2024 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage gene editing company focused on revolutionizing medicine with CRISPR-based therapies...
► Artikel lesen
Seite:  Weiter >>